Article
Therapeutic strategies for IgA nephropathy and kidney fibrosis: a scoping review with computational gap analysis
2026-06-03
Abstract excerpt
<title>Abstract</title> <p>Background: IgA nephropathy (IgAN), the most common primary glomerulonephritis worldwide, leads to end-stage kidney disease in 25–50% of patients and disproportionately affects East and Southeast Asian populations (Ghaddar et al. 2024). Five FDA-approved mechanism-targeted agents entered practice between 2021 and 2025 (U.S. Food and Drug Administration 2026). PS-002, the first registere...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 4fba63dc-3e54-5f5d-9c10-f81fac90dcdd
- DOI
- 10.21203/rs.3.rs-9896876/v1
